How Big Is the Infectious Disease Therapeutics Market | Insights & Trends 2031

Q: What is the expected value of the infectious disease therapeutics market?

The infectious disease therapeutics market is projected to cross USD 90.6 billion by 2031, driven by strong investment and evolving treatment technologies.

Q: Which companies lead the infectious disease therapeutics market?

Leading companies include Pfizer, GSK, Johnson & Johnson, Merck & Co., Roche, and Gilead Sciences, known for their advancements in vaccines, antivirals, and biologics.

Q: What are the latest strategies driving growth in the infectious disease therapeutics market?

Key strategies include faster regulatory approvals, advanced drug delivery systems, and expanded focus on therapeutic access in emerging economies.

Q: How is digital innovation impacting the infectious disease therapeutics market?

Digital platforms and AI are streamlining clinical trials and improving patient outcomes, thus playing a vital role in reshaping the infectious disease therapeutics market.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6669

Publication Date: Jul 2025

How Big Is the Infectious Disease Therapeutics Market?

According to 6Wresearch internal database and industry insights, the Global Infectious Disease Therapeutics Market was valued at USD 56.7 billion in 2024 and is projected to surpass USD 90.6 billion by 2031, growing at a CAGR of 6.90%.during the forecast period (2025-2031).

The market is growing due to rising global disease burdens, new pathogens, and advances in biotechnology and immunotherapy. Strategic engagements among governments, research institutes, and pharmaceutical companies are speeding up therapeutic development. Additionally, the rising demand for broad-spectrum therapies, real-time diagnostics, and outpatient treatments are all factors pushing the market higher.

View Main Report

Schedule Analyst Call

Growth Factors of the Infectious Disease Therapeutics Market

An increase in emerging and reemerging infectious diseases
Expansion of diagnostics tools creating opportunities for early intervention
Significant investment in research & development and clinical trials
Public health policy development strengthening the public health framework
The requirement of innovative monoclonal antibodies and biologics

Infectious Disease Therapeutics Market Trends

Infectious disease therapeutics market is seeing an uptake of biologics, immune modulators, and long-acting injectables. Real-world data and AI-based modelling are changing drug formulation and delivery. Increased government funding and global priorities on pandemic prevention has fuelled drug pipelines.

Emerging Developments in the Infectious Disease Therapeutics Market

Advances in mRNA technologies and CRISPR therapeutics are transforming the infectious disease therapeutics market, enabling more targeted and effective treatments. These advances represent enormous changes in the prevention and management of diseases, and they provide hope for quicker recovery and improved results. At the same time, regulatory agencies are simplifying the applications to be approved, bringing new therapies to patients faster. Moreover, the growth of new platforms for mobile health and tele-health become ways to improve access to care and therapy adherence, especially in lower-resource settings, providing more connections to infectious disease solutions.